Deerfield Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,291,531
| Closed | -$7.57M | – | 115 |
|
|
2016
Q4 | $7.57M | Buy |
+1,291,531
| New | +$7.57M | 0.31% | 66 |
|
|
2015
Q2 | – | Sell |
-765,450
| Closed | -$9.74M | – | 142 |
|
|
2015
Q1 | $9.74M | Sell |
765,450
-418,034
| -35% | -$5.32M | 0.32% | 63 |
|
|
2014
Q4 | $16.7M | Sell |
1,183,484
-50,000
| -4% | -$707K | 0.6% | 42 |
|
|
2014
Q3 | $17M | Sell |
1,233,484
-2,650,925
| -68% | -$36.4M | 0.62% | 45 |
|
|
2014
Q2 | $59.7M | Buy |
3,884,409
+2,481,304
| +177% | +$38.2M | 2.4% | 8 |
|
|
2014
Q1 | $23.9M | Sell |
1,403,105
-80,155
| -5% | -$1.37M | 0.98% | 35 |
|
|
2013
Q4 | $19.2M | Sell |
1,483,260
-2,366,036
| -61% | -$30.6M | 1% | 35 |
|
|
2013
Q3 | $38.8M | Sell |
3,849,296
-2,015,316
| -34% | -$20.3M | 1.81% | 11 |
|
|
2013
Q2 | $43.8M | Buy |
+5,864,612
| New | +$43.8M | 2.06% | 12 |
|